Lupin share price jumps over 3% to hit 52-week high on US FDA approval for drugs
Lupin stock price today rose 3.8% to touch a 52-week high on Friday's trading session after the company received US Food and Drug Administration (US FDA) approval for two of its drug on Thursday. Lupin share price today opened at ₹1,223.95 apiece on BSE, and touched a intraday high of ₹1,241.20, and low of ₹1,213.20 on BSE.
According to technical analysts, the broader trend for the Lupin stock is positive. Lupin's stock price has returned an impressive more than 67% this year.
"The price upmove has been supported by good volumes and hence, the upmove could continue. The support for the stock is now placed around ₹1,150," said Ruchit Jain, Lead Research Analyst at 5paisa.
According to Rajesh Bhosale - Equity Technical and Derivative Analyst, Angel One, today pharma stocks are in momentum and this stock as well is showing positive traction backed with good volumes, one can expect this upmove to continue toward ₹1,300 in near term with strong support around ₹1,190. "Exciting news! Mint is now on WhatsApp Channels
. Read more on livemint.com
